Impact of Rome IV irritable bowel syndrome on work and activities of daily living
- PMID: 35794733
- PMCID: PMC9543519
- DOI: 10.1111/apt.17132
Impact of Rome IV irritable bowel syndrome on work and activities of daily living
Abstract
Background: Few studies have demonstrated the impact of irritable bowel syndrome (IBS) on work and activities of daily living.
Methods: We collected demographic, gastrointestinal symptom, psychological health and quality of life data from 752 adults with Rome IV-defined IBS. We used the work productivity and activity impairment questionnaire for irritable bowel syndrome and the work and social adjustment scale to examine the degree of both impairment at work and in activities of daily living, as well as factors associated with these.
Results: Of 467 individuals who were employed, 133 (28.5%) reported absenteeism, 373 (85.6%) presenteeism and 382 (81.8%) overall work impairment. A mean of 1.97 hours of work per week was lost due to IBS. Extrapolating this across the entire UK, we estimate that between 72 and 188 million hours of work are lost per year due to IBS in individuals of working age. Among all 752 participants, 684 (91.0%) reported any activity impairment with 220 (29.3%) reporting impairment in home management, 423 (56.3%) in social leisure activities, 207 (27.5%) in private leisure activities, and 203 (27.0%) in maintaining close relationships. Severe IBS, higher levels of anxiety, depression, somatization and gastrointestinal symptom-specific anxiety, and lower levels of IBS-related quality of life were associated with impairment in both work and activities of daily living.
Conclusion: Patients with IBS experience a substantial impact on their work and activities of daily living because of their IBS. Future studies should assess the impact of medical interventions on the ability to work and participate in social activities.
Keywords: absenteeism; activities of daily living; irritable bowel syndrome; presenteeism; work.
© 2022 The Authors. Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd.
Figures
Comment in
-
Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome.Aliment Pharmacol Ther. 2022 Sep;56(5):892-893. doi: 10.1111/apt.17143. Aliment Pharmacol Ther. 2022. PMID: 35934848 No abstract available.
-
Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' reply.Aliment Pharmacol Ther. 2022 Sep;56(5):894-895. doi: 10.1111/apt.17160. Aliment Pharmacol Ther. 2022. PMID: 35934862 No abstract available.
References
-
- Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta‐analysis. Lancet Gastroenterol Hepatol. 2020;5(10):908–17. - PubMed
-
- Holtmann GJ, Ford AC, Talley NJ. Pathophysiology of irritable bowel syndrome. Lancet Gastroenterol Hepatol. 2016;1(2):133–46. - PubMed
-
- Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393–407. - PubMed
-
- Black CJ, Drossman DA, Talley NJ, Ruddy J, Ford AC. Functional gastrointestinal disorders: advances in understanding and management. Lancet. 2020;396(10263):1664–74. - PubMed
-
- Black CJ, Craig O, Gracie DJ, Ford AC. Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gut. 2021;70(6):1110–6. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources